# Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45

> **NCT00914043** · — · WITHDRAWN · sponsor: **NSABP Foundation Inc**

## Conditions studied

- Breast Cancer
- Fatigue

## Interventions

- **GENETIC:** gene expression analysis
- **GENETIC:** microarray analysis
- **GENETIC:** polymerase chain reaction
- **GENETIC:** polymorphism analysis
- **GENETIC:** reverse transcriptase-polymerase chain reaction
- **OTHER:** biologic sample preservation procedure
- **OTHER:** enzyme-linked immunosorbent assay
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** fatigue assessment and management

## Key facts

- **NCT ID:** NCT00914043
- **Lead sponsor:** NSABP Foundation Inc
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawn as NCI rescinded approval for parent study NSABP-B-45
- **Last updated:** 2013-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914043, "Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00914043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*